BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24954510)

  • 21. HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer.
    Chen SM; Guo CL; Shi JJ; Xu YC; Chen Y; Shen YY; Su Y; Ding J; Meng LH
    Int J Cancer; 2014 Nov; 135(10):2462-74. PubMed ID: 24706460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth.
    Lang SA; Moser C; Gaumann A; Klein D; Glockzin G; Popp FC; Dahlke MH; Piso P; Schlitt HJ; Geissler EK; Stoeltzing O
    Clin Cancer Res; 2007 Nov; 13(21):6459-68. PubMed ID: 17975158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research on multiple myeloma cell apoptosis by inhibition of mTORC2 and chaperon pathways].
    Fu Y; Zhang Y; Zhang F; Liu J; Gui R
    Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):780-4. PubMed ID: 26462781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells.
    Mori M; Hitora T; Nakamura O; Yamagami Y; Horie R; Nishimura H; Yamamoto T
    Int J Oncol; 2015 Jan; 46(1):47-54. PubMed ID: 25351442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferation of T Lymphocytes via AKT/GSK3β Signaling in MRL/lpr Mice.
    Hong LJ; Chen AJ; Li FZ; Chen KJ; Fang S
    Drug Des Devel Ther; 2020; 14():4605-4612. PubMed ID: 33149557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the Hsp90/Akt pathway in myocardial calpain-induced caspase-3 activation and apoptosis during sepsis.
    Li X; Luo R; Jiang R; Meng X; Wu X; Zhang S; Hua W
    BMC Cardiovasc Disord; 2013 Feb; 13():8. PubMed ID: 23425388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol.
    Solit DB; Basso AD; Olshen AB; Scher HI; Rosen N
    Cancer Res; 2003 May; 63(9):2139-44. PubMed ID: 12727831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3'-epi-12β-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90/Akt/mTOR axis in lung cancer cells.
    Sun Y; Huang YH; Huang FY; Mei WL; Liu Q; Wang CC; Lin YY; Huang C; Li YN; Dai HF; Tan GH
    Theranostics; 2018; 8(7):2044-2060. PubMed ID: 29556372
    [No Abstract]   [Full Text] [Related]  

  • 29. Heat shock protein 90 relieves heat stress damage of myocardial cells by regulating Akt and PKM2 signaling in vivo.
    Zhang XH; Wu JX; Sha JZ; Yang B; Sun JR; Bao ED
    Int J Mol Med; 2020 Jun; 45(6):1888-1908. PubMed ID: 32236591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 17-Allylamino-17-Demethoxygeldanamycin and the Enhancement of PS-341-Induced Lung Cancer Cell Death by Blocking the NF-κB and PI3K/Akt Pathways.
    Lee KH; Jang AH; Yoo CG
    Am J Respir Cell Mol Biol; 2015 Sep; 53(3):412-21. PubMed ID: 25633180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insight into residues involved in the structure and function of the breast cancer associated protein human gamma synuclein.
    Manivel P; Muthukumaran J; Kannan M; Krishna R
    J Mol Model; 2011 Feb; 17(2):251-63. PubMed ID: 20437261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.
    Cervantes-Gomez F; Nimmanapalli R; Gandhi V
    J Pharmacol Exp Ther; 2011 Nov; 339(2):545-54. PubMed ID: 21821695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
    Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
    Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs.
    Singh VK; Zhou Y; Marsh JA; Uversky VN; Forman-Kay JD; Liu J; Jia Z
    Cancer Res; 2007 Jan; 67(2):626-33. PubMed ID: 17234772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of the Hsp90 inhibitor IPI-504 in HER2-positive trastuzumab-resistant breast cancer.
    Scaltriti M; Serra V; Normant E; Guzman M; Rodriguez O; Lim AR; Slocum KL; West KA; Rodriguez V; Prudkin L; Jimenez J; Aura C; Baselga J
    Mol Cancer Ther; 2011 May; 10(5):817-24. PubMed ID: 21383049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
    Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
    Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role of Rab7 in stabilizing EGFR-Her2 and in sustaining Akt survival signal.
    Wang T; Zhang M; Ma Z; Guo K; Tergaonkar V; Zeng Q; Hong W
    J Cell Physiol; 2012 Jun; 227(6):2788-97. PubMed ID: 21928319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinatorial Inhibition of mTORC2 and Hsp90 Leads to a Distinctly Effective Therapeutic Strategy in Malignant Pheochromocytoma.
    Zhang X; Gao F; Zhong S
    Curr Cancer Drug Targets; 2019; 19(9):698-706. PubMed ID: 30727894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors.
    Breinig M; Mayer P; Harjung A; Goeppert B; Malz M; Penzel R; Neumann O; Hartmann A; Dienemann H; Giaccone G; Schirmacher P; Kern MA; Chiosis G; Rieker RJ
    Clin Cancer Res; 2011 Apr; 17(8):2237-49. PubMed ID: 21372220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.
    Ono N; Yamazaki T; Nakanishi Y; Fujii T; Sakata K; Tachibana Y; Suda A; Hada K; Miura T; Sato S; Saitoh R; Nakano K; Tsukuda T; Mio T; Ishii N; Kondoh O; Aoki Y
    Cancer Sci; 2012 Feb; 103(2):342-9. PubMed ID: 22050138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.